World's Best Scientists 2026 revealed!
Bernhard K. Keppler

Bernhard K. Keppler

Award Badge
Chemistry
Austria
2026

D-Index & Metrics

Chemistry

D-Index
105
Citations
42853
World Ranking
996
National Ranking
4

Bernhard K. Keppler publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Bernhard K. Keppler sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 771 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Bernhard K. Keppler D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Bernhard K. Keppler sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 105 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Chemistry in Austria Leader Award
  • 2025 - Research.com Chemistry in Austria Leader Award
  • 2023 - Research.com Chemistry in Austria Leader Award
  • 2022 - Research.com Chemistry in Austria Leader Award

Overview

Bernhard K. Keppler is affiliated with the University of Vienna in Austria. The primary focus of their research lies within the field of Materials Science, encompassing various subfields such as Materials Chemistry, Oncology, Organic Chemistry, Molecular Biology, and Biomaterials.

The scientist has contributed extensively to several main topics including:

  • X-ray Diffraction in Crystallography
  • Crystallization and Solubility Studies
  • Metal complexes synthesis and properties
  • Lanthanide and Transition Metal Complexes
  • Ferrocene Chemistry and Applications
  • Nanoparticle-Based Drug Delivery
  • Drug Transport and Resistance Mechanisms

Frequent publication venues for Keppler's work include:

  • The Cambridge Structural Database
  • Dalton Transactions
  • Pharmaceutics
  • Inorganic Chemistry Frontiers
  • Journal of Inorganic Biochemistry

Their collaborations often involve several co-authors, with notable frequent collaborators being:

  • Michael A. Jakupec
  • Wolfgang Kandioller
  • Michaela Hejl
  • Natalie Gajic
  • Gunda Koellensperger

Selected recent publications include:

  • "Improving the Stability of Maleimide-Thiol Conjugation for Drug Targeting" (2020), Chemistry - A European Journal
  • "Establishing electron diffraction in chemical crystallography" (2021), Nature Reviews Chemistry
  • "Interaction with Ribosomal Proteins Accompanies Stress Induction of the Anticancer Metallodrug BOLD-100/KP1339 in the Endoplasmic Reticulum" (2020), Angewandte Chemie International Edition
  • "Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands" (2021), Journal of Medicinal Chemistry
  • "Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux" (2020), Journal of Medicinal Chemistry

Best Publications

  • From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)

    Christian G. Hartinger;Stefanie Zorbas-Seifried;Michael A. Jakupec;Bernd Kynast

  • KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients.

    Christian G. Hartinger;Christian G. Hartinger;Michael A. Jakupec;Stefanie Zorbas‐Seifried;Michael Groessl

  • Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches.

    Markus Galanski;Michael A. Jakupec;Bernhard K. Keppler

  • NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

    Robert Trondl;Petra Heffeter;Christian R. Kowol;Michael A. Jakupec

  • Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.

    Andrei R Timerbaev;Christian G Hartinger;Svetlana S Aleksenko;Bernhard K Keppler

  • Antitumour metal compounds: more than theme and variations.

    Michael A. Jakupec;Markus Galanski;Vladimir B. Arion;Christian G. Hartinger

  • Recent Developments in the Field of Tumor-Inhibiting Metal Complexes

    M. Galanski;V. B. Arion;M. A. Jakupec;B. K. Keppler

  • Metal complexes in cancer chemotherapy

    Bernhard K. Keppler

  • Anticancer activity of metal complexes: involvement of redox processes.

    Ute Jungwirth;Christian R. Kowol;Bernhard K. Keppler;Christian G. Hartinger

  • Tumour-inhibiting platinum complexes--state of the art and future perspectives.

    M. A. Jakupec;M. Galanski;B. K. Keppler

  • Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development

    Samuel M. Meier-Menches;Samuel M. Meier-Menches;Christopher Gerner;Walter Berger;Walter Berger;Christian G. Hartinger

  • Gallium in cancer treatment.

    Philippe Collery;Bernhard Keppler;Claudie Madoulet;Bernard Desoize

  • Metal Drugs and the Anticancer Immune Response.

    Bernhard Englinger;Christine Pirker;Petra Heffeter;Alessio Terenzi;Alessio Terenzi

  • Resistance against novel anticancer metal compounds: differences and similarities

    Petra Heffeter;Ute Jungwirth;Michael Jakupec;Christian Hartinger

  • The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.

    F Kratz;M Hartmann;B Keppler;L Messori

  • Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

    S. Kapitza;M. Pongratz;M. A. Jakupec;P. Heffeter

  • Electron-transfer activated metal-based anticancer drugs

    Erwin Reisner;Erwin Reisner;Vladimir B. Arion;Bernhard K. Keppler;Armando J.L. Pombeiro

  • Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy

    Martina Pongratz;Petra Schluga;Michael A. Jakupec;Vladimir B. Arion

  • Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study.

    Frederike Lentz;Anne Drescher;Andreas Lindauer;Magdalena Henke

  • Pharmacological properties of cerium compunds

    M. A. Jakupec;P. Unfried;B. K. Keppler

  • Tuning of redox potentials for the design of ruthenium anticancer drugs: an Electrochemical study of [trans-RuCl4L(DMSO)]- and [trans-RuCl4L2]- complexes, where L = imidazole, 1,2,4-triazole, indazole

    Erwin Reisner;Vladimir B Arion;M Fátima C Guedes da Silva;Roman Lichtenecker

Frequent Co-Authors

Michael A. Jakupec
Michael A. Jakupec University of Vienna
Christian G. Hartinger
Christian G. Hartinger University of Auckland
Walter Berger
Walter Berger Medical University of Vienna
Vladimir B. Arion
Vladimir B. Arion University of Vienna
Gunda Koellensperger
Gunda Koellensperger University of Vienna
Andrei R. Timerbaev
Andrei R. Timerbaev University of Vienna
Paul J. Dyson
Paul J. Dyson École Polytechnique Fédérale de Lausanne
Erwin Reisner
Erwin Reisner University of Cambridge
Stephan Hann
Stephan Hann BOKU University
Bernhard Nuber
Bernhard Nuber Heidelberg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to diverse career options beyond traditional laboratory roles. For those interested in healthcare, becoming a pharmacist is a well-respected path. Many students wonder is it hard to become a pharmacist, and while it requires dedication and extensive education, the career offers rewarding opportunities in medicine and patient care.

Another intriguing option is entering the forensic sciences. Careers such as a forensic autopsy technician blend scientific expertise with legal processes. To learn more about this role, explore what it takes to become a forensic autopsy technician, including education requirements and job outlook.

For students aiming to work in forensic science, pursuing a forensic science degree online can offer flexible learning options. These programs prepare graduates for roles in criminal investigations and laboratory analysis without the need for on-campus attendance.

Additionally, those interested in the psychological aspects of forensics might consider advancing their studies with an online forensic psychology masters. This advanced degree supports careers in criminal profiling, counseling, and criminal justice system consulting.

Best Scientists Citing Bernhard K. Keppler

Trending Scientists